The whys and hows of hematopoietic progenitor and stem cell mobilization

A. Kessinger, John G Sharp

Research output: Contribution to journalShort survey

54 Citations (Scopus)

Abstract

Intentional mobilization of hematopoietic/stem cells into the circulation has improved the efficiency of their collection. Transplantation of mobilized blood stem cells to patients with marrow aplasia results in a faster pace of hematopoietic recovery than transplantation of marrow-derived stem cells. Autologous and allogeneic hematopoietic stem cell transplantation are increasingly performed with blood-derived cells. Donors of both autologous and allogeneic blood stem cells do not always respond well to therapies designed to produce mobilization. Autologous donors may respond poorly as a result of myelotoxic damage inflicted by prior antitumor therapy, but this explanation is not valid for allogeneic donors. The mechanism(s) involved in the process of mobilization are incompletely understood. Until these mechanisms are elucidated, methods to improve mobilization vigor on a rational basis will not be obvious. In the meanwhile, clinical observations may provide some hints regarding the whys and hows of mobilization and permit incremental improvements in this process.

Original languageEnglish (US)
Pages (from-to)319-329
Number of pages11
JournalBone marrow transplantation
Volume31
Issue number5
DOIs
StatePublished - Mar 1 2003

Fingerprint

Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cells
Blood Cells
Stem Cells
Tissue Donors
Transplantation
Bone Marrow
Hematopoietic Stem Cell Transplantation
Therapeutics

Keywords

  • Mobilization
  • Progenitor
  • Stem cell

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The whys and hows of hematopoietic progenitor and stem cell mobilization. / Kessinger, A.; Sharp, John G.

In: Bone marrow transplantation, Vol. 31, No. 5, 01.03.2003, p. 319-329.

Research output: Contribution to journalShort survey

@article{c1da3e050b694b08befa4eaa444f4db9,
title = "The whys and hows of hematopoietic progenitor and stem cell mobilization",
abstract = "Intentional mobilization of hematopoietic/stem cells into the circulation has improved the efficiency of their collection. Transplantation of mobilized blood stem cells to patients with marrow aplasia results in a faster pace of hematopoietic recovery than transplantation of marrow-derived stem cells. Autologous and allogeneic hematopoietic stem cell transplantation are increasingly performed with blood-derived cells. Donors of both autologous and allogeneic blood stem cells do not always respond well to therapies designed to produce mobilization. Autologous donors may respond poorly as a result of myelotoxic damage inflicted by prior antitumor therapy, but this explanation is not valid for allogeneic donors. The mechanism(s) involved in the process of mobilization are incompletely understood. Until these mechanisms are elucidated, methods to improve mobilization vigor on a rational basis will not be obvious. In the meanwhile, clinical observations may provide some hints regarding the whys and hows of mobilization and permit incremental improvements in this process.",
keywords = "Mobilization, Progenitor, Stem cell",
author = "A. Kessinger and Sharp, {John G}",
year = "2003",
month = "3",
day = "1",
doi = "10.1038/sj.bmt.1703837",
language = "English (US)",
volume = "31",
pages = "319--329",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - The whys and hows of hematopoietic progenitor and stem cell mobilization

AU - Kessinger, A.

AU - Sharp, John G

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Intentional mobilization of hematopoietic/stem cells into the circulation has improved the efficiency of their collection. Transplantation of mobilized blood stem cells to patients with marrow aplasia results in a faster pace of hematopoietic recovery than transplantation of marrow-derived stem cells. Autologous and allogeneic hematopoietic stem cell transplantation are increasingly performed with blood-derived cells. Donors of both autologous and allogeneic blood stem cells do not always respond well to therapies designed to produce mobilization. Autologous donors may respond poorly as a result of myelotoxic damage inflicted by prior antitumor therapy, but this explanation is not valid for allogeneic donors. The mechanism(s) involved in the process of mobilization are incompletely understood. Until these mechanisms are elucidated, methods to improve mobilization vigor on a rational basis will not be obvious. In the meanwhile, clinical observations may provide some hints regarding the whys and hows of mobilization and permit incremental improvements in this process.

AB - Intentional mobilization of hematopoietic/stem cells into the circulation has improved the efficiency of their collection. Transplantation of mobilized blood stem cells to patients with marrow aplasia results in a faster pace of hematopoietic recovery than transplantation of marrow-derived stem cells. Autologous and allogeneic hematopoietic stem cell transplantation are increasingly performed with blood-derived cells. Donors of both autologous and allogeneic blood stem cells do not always respond well to therapies designed to produce mobilization. Autologous donors may respond poorly as a result of myelotoxic damage inflicted by prior antitumor therapy, but this explanation is not valid for allogeneic donors. The mechanism(s) involved in the process of mobilization are incompletely understood. Until these mechanisms are elucidated, methods to improve mobilization vigor on a rational basis will not be obvious. In the meanwhile, clinical observations may provide some hints regarding the whys and hows of mobilization and permit incremental improvements in this process.

KW - Mobilization

KW - Progenitor

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=0037355362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037355362&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703837

DO - 10.1038/sj.bmt.1703837

M3 - Short survey

C2 - 12634722

AN - SCOPUS:0037355362

VL - 31

SP - 319

EP - 329

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 5

ER -